Suchergebnisse - "Weis, Nina"

PubPharm (12)

1

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD) : 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

enthalten in: The lancet. HIV | 2020

von Molina, J. | Squires, K. | Sax, P. | +112

CommentIn: Lancet HIV. 2020 Jan;7(1):e2-e3. - PMID 31740350

2

Study protocol : becoming and being a mother living with HIV - a multicentre longitudinal mixed methods study among pregnant women living with HIV, non-pregnant women living with HIV and pregnant women not living with HIV in a high-income setting (the 2B MOM study)

enthalten in: BMJ open | 2019

von Moseholm, E. | Fetters, M. | Aho, I. | +6

3

Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals : a clinical randomized study

enthalten in: European journal of gastroenterology & hepatology | 2018

von Sølund, C. | Andersen, E. | Mössner, B. | +10

4

Analytical performance of the Hologic Aptima HBV Quant Assay and the COBAS Ampliprep/COBAS TaqMan HBV test v2.0 for the quantification of HBV DNA in plasma samples

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2018

von Schønning, K. | Johansen, K. | Nielsen, L. | +2

5

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD) : 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

enthalten in: The lancet. HIV | 2018

von Molina, J. | Squires, K. | Sax, P. | +113

CommentIn: Lancet HIV. 2018 May;5(5):e200-e201. - PMID 29592841

6

Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples

enthalten in: Journal of virological methods | 2017

von Schønning, K. | Pedersen, M. | Johansen, K. | +4

7

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY) : a randomised, open-label phase 2 trial

enthalten in: Lancet (London, England) | 2015

von Sulkowski, M. | Hezode, C. | Gerstoft, J. | +20

CommentIn: Lancet. 2015 Mar 21;385(9973):1050-2. - PMID 25468162

8

Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients : results from the DANVIR cohort study

enthalten in: International journal of cancer | 2012

von Omland, L. | Jepsen, P. | Krarup, H. | +7

9

Mortality among patients with cleared hepatitis C virus infection compared to the general population : a Danish nationwide cohort study

enthalten in: PloS one | 2011

von Omland, L. | Christensen, P. | Krarup, H. | +25

10

Influence of Factor V Leiden on susceptibility to and outcome from critical illness : a genetic association study

enthalten in: Critical care (London, England) | 2010

von Benfield, T. | Ejrnaes, K. | Juul, K. | +9